ArticleAdvances in radiation oncology

Long-Term Outcomes of a Phase I Trial of Weekly Docetaxel, Total Androgen Blockade, and Image Guided Intensity Modulated Radiation Therapy for Localized High-Risk Prostate Adenocarcinoma.

Shauna McVorran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.